KALY Announces New HempTantation CBD Sunscreen For $17 Billion Market
Dallas, TX– May 2, 2019 – Kali-Extracts, Inc. (OTCPK: KALY) (Kali, Inc. dba/Kali-Extracts, Inc.) (“KALY”) today announced the all new HempTantation, a hemp derived CBD infused sunscreen. KALY has a U.S. Patented cannabis extraction process. The company is conducting ongoing research and development with its cannabis extracts to develop a variety of pharmaceutical treatments for a range of health conditions to include pain management, various lung diseases and type 2 diabetes. At the same time the company is developing and launching its own line of wellness and cosmetic products as well as partnering with other companies to produce additional wellness and cosmetic products. KALY currently sells Hemp4mula CBD infused gum and has licensed its patented cannabis extraction process to Puration, Inc. (USOTC: PURA) (“PURA”) for the production of EVERx CBD Sports Water. PURA’s infusion and bottling experience and capacity has been instrumental in KALY’s development of HempTantation. KALY’s Hemp4mula CBD infused gum and PURA’s EVERx CBD Sports Water are both available for sale now online from the North American Cannabis Holdings (USOTC: USMJ) (“USMJ”) Ecommerce site, USMJ.com. HempTantation is scheduled to be available for sale this summer from USMJ.com in addition to other online and brick and mortar retail outlets. Look for a HempTantation product launch announcement coming soon.
KALY is targeting the $17 billion global sun protection product market. In informal, non-medical, trials of KALY’s CBD infused lotion, users have reported the CBD formula has proven effective not only for protection from the sun, but relief and repair from sunburn.
The HempTantation product name has been developed in conjunction with a marketing campaign designed to rapidly establish brand recognition. Look for more details on the marketing campaign when KALY announces the official HempTantaion product launch.
To learn more about the company visit https://www.kali-extracts.com/
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company’s actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.
SOURCE: Kali-Extracts, Inc.